| Objective evaluation of multiple sclerosis lesion segmentation using a data management and processing infrastructure O Commowick, A Istace, M Kain, B Laurent, F Leray, M Simon, SC Pop, ... Scientific reports 8 (1), 13650, 2018 | 236 | 2018 |
| Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks C Gros, B De Leener, A Badji, J Maranzano, D Eden, SM Dupont, ... Neuroimage 184, 901-915, 2019 | 227 | 2019 |
| MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. C Till, R Ghassemi, B Aubert-Broche, A Kerbrat, DL Collins, S Narayanan, ... Neuropsychology 25 (3), 319, 2011 | 195 | 2011 |
| Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase A Kerbrat, JC Ferré, P Fillatre, T Ronzière, S Vannier, B Carsin-Nicol, ... New England Journal of Medicine 375 (18), 1717-1725, 2016 | 189 | 2016 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 106 | 2021 |
| Spatial distribution of multiple sclerosis lesions in the cervical spinal cord D Eden, C Gros, A Badji, SM Dupont, B De Leener, J Maranzano, ... Brain 142 (3), 633-646, 2019 | 99 | 2019 |
| Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS A Kerbrat, B Aubert-Broche, V Fonov, S Narayanan, JG Sled, DA Arnold, ... Neurology 78 (3), 194-201, 2012 | 96 | 2012 |
| Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients A Kerbrat, E Le Page, E Leray, T Anani, M Coustans, C Desormeaux, ... Journal of the neurological sciences 308 (1-2), 98-102, 2011 | 96 | 2011 |
| Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability A Kerbrat, C Gros, A Badji, E Bannier, F Galassi, B Combès, R Chouteau, ... Brain 143 (7), 2089-2105, 2020 | 47 | 2020 |
| Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis? J Bonenfant, E Bajeux, V Deburghgraeve, E Le Page, G Edan, A Kerbrat European Journal of Neurology 24 (2), 237-244, 2017 | 38 | 2017 |
| Multiple sclerosis lesions segmentation from multiple experts: The MICCAI 2016 challenge dataset O Commowick, M Kain, R Casey, R Ameli, JC Ferré, A Kerbrat, T Tourdias, ... Neuroimage 244, 118589, 2021 | 37 | 2021 |
| Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study S Demuth, M Guillaume, B Bourre, J Ciron, H Zephir, Y Sirejacob, ... Journal of Neuroinflammation 19 (1), 62, 2022 | 30 | 2022 |
| Register‐based incidence of multiple sclerosis in Brittany (north‐western France), 2000–2001 J Yaouanq, I Tron, A Kerbrat, E Leray, S Hamonic, M Merienne, P Hinault, ... Acta Neurologica Scandinavica 131 (5), 321-328, 2015 | 27 | 2015 |
| Centering inclusivity in the design of online conferences—An OHBM–Open Science perspective E Levitis, CDG Van Praag, R Gau, S Heunis, E DuPre, G Kiar, ... GigaScience 10 (8), giab051, 2021 | 25 | 2021 |
| Ten‐year prognosis in multiple sclerosis: a better outcome in relapsing− remitting patients but not in primary progressive patients A Kerbrat, S Hamonic, E Leray, I Tron, G Edan, J Yaouanq, ... European Journal of Neurology 22 (3), 507-e35, 2015 | 19 | 2015 |
| Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: a multicentre magnetisation transfer ratio study B Combès, A Kerbrat, JC Ferré, V Callot, J Maranzano, A Badji, ... Multiple Sclerosis Journal 25 (8), 1113-1123, 2019 | 18 | 2019 |
| Infections and multiple sclerosis: recommendations from the French multiple sclerosis society C Papeix, C Donze, C Lebrun-Frénay, C Donzé, D Laplaud, E Thouvenot, ... Revue Neurologique 177 (8), 980-994, 2021 | 16 | 2021 |
| Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis K Ahrweiller, C Rousseau, E Le Page, E Bajeux, E Leray, L Michel, ... Multiple Sclerosis Journal 26 (8), 924-935, 2020 | 14 | 2020 |
| Discontinuation of second-versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis M Chappuis, C Rousseau, E Bajeux, S Wiertlewski, D Laplaud, E Le Page, ... Journal of Neurology 270 (1), 413-422, 2023 | 13 | 2023 |
| The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind … K Metzger-Peter, LD Kremer, G Edan, P Loureiro De Sousa, J Lamy, ... Trials 21, 1-11, 2020 | 13 | 2020 |
